Predicting smoking cessation. Who will quit with and without the nicotine patch.

A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry (2009) 4.66

Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris. BMJ (1994) 4.49

Distress tolerance and early smoking lapse. Clin Psychol Rev (2005) 2.61

Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry (2010) 2.45

New methods for tobacco dependence treatment research. Ann Behav Med (2011) 2.44

The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med (2011) 2.43

Menstrual phase effects on smoking relapse. Addiction (2008) 2.33

Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ (1994) 2.25

Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug Alcohol Depend (2009) 2.01

Attentional bias predicts outcome in smoking cessation. Health Psychol (2003) 1.96

Modeling the effect of alcohol on smoking lapse behavior. Psychopharmacology (Berl) (2006) 1.95

Stress decreases the ability to resist smoking and potentiates smoking intensity and reward. J Psychopharmacol (2010) 1.86

Adapting smoking cessation treatment according to initial response to precessation nicotine patch. Am J Psychiatry (2013) 1.71

Comparing two web-based smoking cessation programs: randomized controlled trial. J Med Internet Res (2008) 1.65

Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h. Psychopharmacology (Berl) (2005) 1.61

Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement. Psychopharmacology (Berl) (2007) 1.55

Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. J Clin Psychiatry (2015) 1.51

Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Br J Gen Pract (1996) 1.38

Role of progesterone in nicotine addiction: evidence from initiation to relapse. Exp Clin Psychopharmacol (2010) 1.38

Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy. Psychopharmacology (Berl) (2005) 1.37

Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function. Behav Pharmacol (2009) 1.29

Developing human laboratory models of smoking lapse behavior for medication screening. Addict Biol (2008) 1.26

Contingency management in the 21st century: technological innovations to promote smoking cessation. Subst Use Misuse (2011) 1.21

Clinico-epidemiological profile of tobacco users attending a tobacco cessation clinic in a teaching hospital in Bangalore city. Lung India (2012) 1.20

The Wisconsin Predicting Patients' Relapse questionnaire. Nicotine Tob Res (2009) 1.20

Sociodemographic predictors of success in smoking intervention. Tob Control (2001) 1.19

Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. J Appl Behav Anal (2008) 1.17

Usage patterns of transdermal nicotine when purchased as a non-prescription medicine from pharmacies. Tob Control (1998) 1.15

Nicotine vaccines to assist with smoking cessation: current status of research. Drugs (2012) 1.14

Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats. Drug Alcohol Depend (2011) 1.13

Relapse dynamics during smoking cessation: recurrent abstinence violation effects and lapse-relapse progression. J Abnorm Psychol (2011) 1.12

Predictors of long-term outcome of a smoking cessation programme in primary care. Br J Gen Pract (2003) 1.12

Internet-based contingency management to promote smoking cessation: a randomized controlled study. J Appl Behav Anal (2013) 1.11

Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence. Psychopharmacology (Berl) (2009) 1.10

The use of financial incentives in promoting smoking cessation. Prev Med (2012) 1.08

Treating tobacco dependence in a medical setting. CA Cancer J Clin (2009) 1.08

Predictors of continued smoking over 25 years of follow-up in the normative aging study. Am J Public Health (2000) 1.07

Internet-based group contingency management to promote abstinence from cigarette smoking: a feasibility study. Drug Alcohol Depend (2011) 1.06

Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial. JAMA Psychiatry (2014) 1.06

A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Exp Clin Psychopharmacol (2010) 1.06

Influence of the duration of abstinence on the relative reinforcing effects of cigarette smoking. Psychopharmacology (Berl) (2005) 1.06

Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine Tob Res (2012) 1.05

Early abstinence in cocaine pharmacotherapy trials predicts successful treatment outcomes. J Subst Abuse Treat (2009) 1.03

Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers. Psychoneuroendocrinology (2010) 1.03

Predictors of lapse in first week of smoking abstinence in PTSD and non-PTSD smokers. Nicotine Tob Res (2012) 1.03

Prerelease intent predicts smoking behavior postrelease following a prison smoking ban. Nicotine Tob Res (2009) 1.01

Nicotine and food deprivation decrease the ability to resist smoking. Psychopharmacology (Berl) (2010) 1.01

A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation. Drug Alcohol Depend (2012) 1.00

Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers. J Gen Intern Med (2006) 1.00

Patterns of motivations and ways of quitting smoking among Polish smokers: a questionnaire study. BMC Public Health (2008) 0.99

I am your smartphone, and I know you are about to smoke: the application of mobile sensing and computing approaches to smoking research and treatment. Nicotine Tob Res (2013) 0.98

Patterns of self-selected smoking cessation attempts and relapse by menstrual phase. Addict Behav (2009) 0.95

An evidence-based programme for smoking cessation: effectiveness in routine general practice. Br J Gen Pract (2000) 0.94

Predicting successful 24-hr quit attempt in a smoking cessation intervention. Nicotine Tob Res (2011) 0.94

Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans. Psychopharmacology (Berl) (2009) 0.92

Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia. Nicotine Tob Res (2013) 0.92

Identifying effective intervention components for smoking cessation: a factorial screening experiment. Addiction (2015) 0.91

An overview of principles of effective treatment of substance use disorders and their potential application to pregnant cigarette smokers. Drug Alcohol Depend (2009) 0.90

Abstinence-related expectancies predict smoking withdrawal effects: implications for possible causal mechanisms. Psychopharmacology (Berl) (2013) 0.89

Attrition in a multi-component smoking cessation study for females. Tob Induc Dis (2006) 0.89

An ecological momentary assessment analysis of prequit markers for smoking-cessation failure. Exp Clin Psychopharmacol (2012) 0.89

Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials. Pharmacogenomics J (2008) 0.89

Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.89

Functional data analysis for dynamical system identification of behavioral processes. Psychol Methods (2013) 0.88

Effects of escalating and descending schedules of incentives on cigarette smoking in smokers without plans to quit. J Appl Behav Anal (2010) 0.88

The relationship between in-treatment abstinence and post-treatment abstinence in a smoking cessation treatment. Exp Clin Psychopharmacol (2010) 0.88

Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density. Neuropsychopharmacology (2013) 0.88

Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation. Psychol Res Behav Manag (2011) 0.88

Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials. Drug Alcohol Depend (2010) 0.87

The first 7 days of a quit attempt predicts relapse: validation of a measure for screening medications for nicotine dependence. J Addict Med (2013) 0.87

Early lapses in a cessation attempt: lapse contexts, cessation success, and predictors of early lapse. Nicotine Tob Res (2013) 0.86

Survival Analysis with Time-Varying Covariates Measured at Random Times by Design. J R Stat Soc Ser C Appl Stat (2013) 0.86

Predictors of adherence to nicotine gum and counseling among African-American light smokers. J Gen Intern Med (2010) 0.85

Effects of initial abstinence and programmed lapses on the relative reinforcing effects of cigarette smoking. J Appl Behav Anal (2008) 0.85

Conceptualizing analyses of ecological momentary assessment data. Nicotine Tob Res (2013) 0.85

Enhancing the effectiveness of smoking treatment research: conceptual bases and progress. Addiction (2015) 0.84

An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology (Berl) (2013) 0.84

Comparative effectiveness of intervention components for producing long-term abstinence from smoking: a factorial screening experiment. Addiction (2015) 0.83

Paths to tobacco abstinence: A repeated-measures latent class analysis. J Consult Clin Psychol (2015) 0.83

Smoking reductions and increased self-efficacy in a randomized controlled trial of smoking abstinence-contingent incentives in residential substance abuse treatment patients. Nicotine Tob Res (2014) 0.83

Intolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disorders. Addict Behav (2014) 0.83

Individual and combined effects of multiple high-risk triggers on postcessation smoking urge and lapse. Nicotine Tob Res (2013) 0.83

Effects of Smoking Cessation on Illicit Drug Use among Opioid Maintenance Patients: A Pilot Study. J Drug Issues (2009) 0.83

Examining the timing of changes in cigarette smoking upon learning of pregnancy. Prev Med (2014) 0.82

Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced craving. Br J Clin Pharmacol (2002) 0.82

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. Addiction (2010) 0.82

Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients. Exp Clin Psychopharmacol (2011) 0.82

A before-after implementation trial of smoking cessation guidelines in hospitalized veterans. Implement Sci (2009) 0.82

A Context-Sensing Mobile Phone App (Q Sense) for Smoking Cessation: A Mixed-Methods Study. JMIR Mhealth Uhealth (2016) 0.82

Consideration of sex in clinical trials of transdermal nicotine patch: a systematic review. Exp Clin Psychopharmacol (2014) 0.81

Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. CNS Drugs (2015) 0.81

Defining and predicting short-term alcohol use changes during a smoking cessation attempt. Addict Behav (2015) 0.81

Negative reinforcement smoking outcome expectancies are associated with affective response to acute nicotine administration and abstinence. Drug Alcohol Depend (2011) 0.81

Pre-quitting nicotine replacement therapy: findings from a pilot study. Tob Induc Dis (2006) 0.80

Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence. Exp Clin Psychopharmacol (2012) 0.79

With others or alone? Adolescent individual differences in the context of smoking lapses. Health Psychol (2015) 0.79

Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study. Tob Induc Dis (2012) 0.78

Is delaying a quit attempt associated with less success? Nicotine Tob Res (2011) 0.78

Prize contingency management for smoking cessation: a randomized trial. Drug Alcohol Depend (2014) 0.78

The role of nicotine replacement therapy in early quitting success. Nicotine Tob Res (2009) 0.78

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med (1999) 10.62

Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res (1989) 7.78

The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA (1994) 6.02

Trends in cigarette smoking in the United States. Educational differences are increasing. JAMA (1989) 5.59

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA (1997) 5.47

Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA (1989) 4.90

Tobacco dependence and the nicotine patch. Clinical guidelines for effective use. JAMA (1992) 3.77

The reliability of self-reported cigarette consumption in the United States. Am J Public Health (1989) 3.35

Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol (1999) 3.21

Gender differences in smoking cessation. J Consult Clin Psychol (1999) 2.84

Varying nicotine patch dose and type of smoking cessation counseling. JAMA (1995) 2.82

Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J Clin Microbiol (1986) 2.79

The motivation to use drugs: a psychobiological analysis of urges. Nebr Symp Motiv (1986) 2.56

Cigarette smoking prevalence by occupation in the United States. A comparison between 1978 to 1980 and 1987 to 1990. J Occup Med (1994) 2.52

US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care (2000) 2.44

Quitting smoking in the United States in 1986. J Natl Cancer Inst (1990) 2.42

Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33

Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. Mayo Clin Proc (1995) 2.32

Postcessation cigarette use: the process of relapse. Addict Behav (1990) 2.21

Smoking withdrawal dynamics in unaided quitters. J Abnorm Psychol (2000) 2.11

Hairpins are formed by the single DNA strands of the fragile X triplet repeats: structure and biological implications. Proc Natl Acad Sci U S A (1995) 2.10

Smoking outcome expectancies: factor structure, predictive validity, and discriminant validity. J Abnorm Psychol (1994) 2.06

Profiles in discouragement: two studies of variability in the time course of smoking withdrawal symptoms. J Abnorm Psychol (1998) 1.84

RglB facilitated cloning of highly methylated eukaryotic DNA: the human L1 transposon, plant DNA, and DNA methylated in vitro with human DNA methyltransferase. Nucleic Acids Res (1988) 1.71

Race/ethnicity and the 2000 census: implications for public health. Am J Public Health (2000) 1.61

Smoking cessation treatment and the good doctor club. Am J Public Health (1995) 1.60

CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain. Am J Physiol (1997) 1.57

CFTR: mechanism of anion conduction. Physiol Rev (1999) 1.55

Response to nicotine dependence treatment in smokers with current and past alcohol problems. Ann Behav Med (1999) 1.54

Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Exp Clin Psychopharmacol (1999) 1.47

The effects of athletic massage on delayed onset muscle soreness, creatine kinase, and neutrophil count: a preliminary report. J Orthop Sports Phys Ther (1994) 1.40

Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res (2001) 1.36

Trends in smoking by age and sex, United States, 1974-1987: the implications for disease impact. Prev Med (1990) 1.35

DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis (1995) 1.31

Transdermal nicotine replacement for hospitalized patients: a randomized clinical trial. Prev Med (1998) 1.31

Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore. Biophys J (1998) 1.30

Relation between self-reported affect and drug urges and cravings in continuing and withdrawing smokers. J Abnorm Psychol (1992) 1.29

Evaluating the construct validity of psychopathy in black and white male inmates: three preliminary studies. J Abnorm Psychol (1990) 1.24

Using brain MERMER testing to detect knowledge despite efforts to conceal. J Forensic Sci (2001) 1.22

Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res (1999) 1.22

Gender and racial/ethnic differences in tobacco-dependence treatment: a commentary and research recommendations. Nicotine Tob Res (2001) 1.20

Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. J Consult Clin Psychol (1992) 1.19

Any further progress in smoking cessation treatment? Nicotine Tob Res (2001) 1.18

Manipulating smoking motivation: impact on an electrophysiological index of approach motivation. J Abnorm Psychol (1999) 1.17

Assessing the generalizability of smoking studies. Addiction (1997) 1.17

Approach and avoidance motivation in psychopathic criminal offenders during passive avoidance. J Pers Soc Psychol (1997) 1.17

Purification of human DNA (cytosine-5-)-methyltransferase. J Cell Biochem (1985) 1.16

Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Prev Med (2000) 1.14

Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments. Chest (1994) 1.13

Size of the directing moiety at carbon 5 of cytosine and the activity of human DNA(cytosine-5) methyltransferase. Biochem Biophys Res Commun (1987) 1.12

Quantification of lumbar function. Part 2: Sagittal plane trunk strength in chronic low-back pain patients. Spine (Phila Pa 1976) (1985) 1.10

Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats. J Pharmacol Exp Ther (2003) 1.09

Smokeless tobacco use in the United States: the adult use of tobacco surveys. NCI Monogr (1989) 1.09

Gender differences in chronic disease risk behaviors through the transition out of high school. Am J Prev Med (1999) 1.09

Carcinoma of the breast. A clinical study. Arch Surg (1978) 1.05

The epidemiology of tobacco use, dependence, and cessation in the United States. Prim Care (1999) 1.04

Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacology (Berl) (1996) 1.04

Progesterone withdrawal I: pro-convulsant effects. Brain Res (1998) 1.03

Initial ATP Formation, NADP Reduction, CO(2) Fixation, and Chloroplast Flattening Upon Illuminating Pea Leaves. Plant Physiol (1969) 1.01

The influence of agarose--DNA affinity on the electrophoretic separation of DNA fragments in agarose gels. Anal Biochem (1983) 0.98

Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal. Eur J Neurosci (2003) 0.98

Tobacco withdrawal and nicotine replacement influence objective measures of sleep. J Consult Clin Psychol (1995) 0.98

Reversal of somatostatin inhibition of insulin and glucagon secretion. Diabetes (1976) 0.97

Under-use of tobacco dependence treatment among Wisconsin's fee-for-service Medicaid recipients. WMJ (2001) 0.96

Progesterone withdrawal. II: insensitivity to the sedative effects of a benzodiazepine. Brain Res (1998) 0.96

Quadruplex DNA formation in a region of the tRNA gene supF associated with hydrogen peroxide mediated mutations. Biochemistry (1991) 0.95

CFTR: covalent modification of cysteine-substituted channels expressed in Xenopus oocytes shows that activation is due to the opening of channels resident in the plasma membrane. J Gen Physiol (2001) 0.94

Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats. Neuropharmacology (2002) 0.94